Scholars Central

Conference abstractPublished 2017

The molecular basis of the neurotrophic action of vitamin B12 (Cobalamin)

Authors: Giuseppe Scalabrino

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Our experimental and clinical studies have highlighted the non-coenzyme functions of cobalamin (Cbl, vitamin B12). Cytokine and growth factor (GF) imbalance in the central nervous system (CNS) of Cbl-deficient (Cbl-D) rats is a key point in the pathogenesis of Cbl-D neuropathy. The increased molecules are tumour necrosis factor (TNF)-Ã?±, nerve GF and the soluble (s) CD40:sCD40Ligand dyad; the decreased molecules are epidermal GF (EGF) and interleukin-6. The in vivo administration of the lacking myelinotrophic molecules or agents antagonizing the excess myelintoxic agent is as effective as Cbl in repairing or preventing Cbl-deficiency-induced CNS myelin lesions. Cbl deficiency morphologically affects also glial cells, which normally synthesize and release various cytokines and GFs. Therefore, Cbl deficiency triggers the rearrangements of glia gene expression, eventually leading to a changed pattern of cytokine and GF production. Such an opposite imbalance in TNF-Ã?± and EGF similar to that observed in CNS of Cbl-D rats has been found in the sera of adult patients with pernicious anaemia (but not in patients with iron-deficient anaemia) and it was rectified by Cbl therapy. This imbalance has also been found in the cerebrospinal fluid (CSF) of adult patients with Cbl-D neuropathy. Given that TNF-Ã?± and EGF regulate the expression of normal prions (PrPcs) and PrPcs play a crucial role in myelin maintenance, we investigated whether CNS PrPc levels are indirectly regulated by Cbl. PrPc levels had increased by the time Cbl- D-induced myelin lesions appeared. This increase was mediated by excess TNF-Ã?± and prevented by EGF. Cbl deficiency greatly reduced CNS PrPc-mRNA levels, which were subsequently increased by Cbl and EGF. Similar increases in PrPc levels also occur in the serum and CSF of adult Cbl-D patients, and the serum increase has been corrected by Cbl therapy. Therefore, Cbl may regulate the PrPc levels in the serum and CSF in humans.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Neuroscience and Neuropharmacology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Neuroscience and Neuropharmacology
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Giuseppe Scalabrino”